Characterization of an FcgammaRI-binding peptide selected by phage display

Area of Science:

• Immunology
• Molecular Biology
• Biotechnology

Background:

• The high-affinity IgG receptor, Fcgamma receptor I (FcgammaRI), is exclusively expressed on myeloid cells.
• Targeting FcgammaRI is of interest for vaccine antigen delivery, but current reagents like antibodies are large and complex.
• There is a need for smaller, simpler FcgammaRI-targeting molecules.

Purpose of the Study:

• To identify and characterize small peptides that bind specifically to FcgammaRI.
• To evaluate the potential of these peptides as targeting reagents for FcgammaRI-expressing cells.

Main Methods:

• Screening of phage display peptide libraries using the human monocytic cell line U937.
• Selection of phages displaying FcgammaRI-binding consensus peptides (CLRSGXGC).
• Binding assays with FcgammaRI-transfected cells, soluble FcgammaRI domains, and other Fcgamma receptors (FcgammaRIIA, FcgammaRIIB, FcgammaRIIIB).
• Flow cytometry and internalization studies using synthetic biotin-conjugated peptides.

Main Results:

• Phages displaying the consensus peptide showed increased binding to IFN-gamma stimulated U937 cells and FcgammaRI-transfected cells.
• Selected peptides bound specifically to FcgammaRI and its extracellular domains, but not to other Fcgamma receptors.
• Synthetic peptides inhibited phage binding and demonstrated targeting of FcgammaRI-expressing cells.
• A synthetic peptide promoted internalization and degradation of streptavidin-coupled magnetic beads.

Conclusions:

• Small peptides capable of specifically binding FcgammaRI were identified using phage display.
• These FcgammaRI-binding peptides can target myeloid cells and facilitate internalization.
• The identified peptides represent promising, smaller alternatives to antibodies for FcgammaRI-based targeting strategies.